Predictors of virologic outcome among people living with hiv who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance

HIGHLIGHTS

• who: Robert A. Salata from the (India and Thailand)The design has previously been described in detail [7, ]. Key eligibility criteria included people aged u2265 , years living with HIV previously treated with an NNRTI-based regimen replaced by a PI-based regimen, with the change due to toxicity or virologic failure. Participants had to be experiencing virologic failure defined as two consecutive measurements of plasma , RNA u2265 , copies/mL obtained at least one day apart after at least , weeks on the same PI-based regimen. Ethical approvals were obtained from the institution review boards at all the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.